“Bimekizumab Impact on Pain in Moderate to Severe Hidradenitis Suppurativa: Week 16 Results from BE HEARD I & II”. 2024. SKIN The Journal of Cutaneous Medicine 8 (1): s350. https://doi.org/10.25251/skin.8.supp.350.